search
Back to results

iCycle II: Recovery of Function Through FES Cycling With VR Biofeedback in People With SCI. (iCycle)

Primary Purpose

Spinal Cord Injuries

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
iCycle Mark 3
Sponsored by
University College, London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Spinal Cord Injuries focused on measuring Rehabilitation, FES cycling, Virtual Reality, Biofeedback, Motor Function

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • >18 years
  • Incomplete SCI above T12
  • >12 months post injury
  • Respond to FES
  • No deteriorating condition or other co-morbidity that would make participation impractical or unsafe.
  • Marginal walker defined as able to rise from a chair, stand for 10 seconds and walk >10 steps without human help (but may use an aid including parallel bars).

Exclusion Criteria:

  • Cardiac pacemaker
  • Pressure sores/skin problems
  • Unhealed lower limb fractures
  • Pregnancy
  • Active heterotrophic ossification - lower limbs
  • Severe osteoporosis
  • Complex regional pain syndrome
  • Implanted metal work at electrode site (< 3/12)
  • Lower Limb Malignancy
  • T6 and below spinal malignancy
  • Uncontrolled autonomic dysreflexia
  • History of knee dislocation/subluxation
  • Allergy to electrodes
  • Cognitive difficulties - must be able to demonstrate an understanding of the iCycle and the virtual reality cycling game
  • Severe spasticity - Ashworth scale 4 or 5 in any lower limb muscle groups
  • Neurological degenerative diseases

Sites / Locations

  • Royal National Orthopaedic HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

iCycle training

Arm Description

Participants will attend 3 training sessions per week at the RNOH. During these sessions, participants will tether their wheelchair (from under the seat) to the front of the iCycle, and their feet will be attached to the iCycle pedals. For training, participants will complete virtual reality cycle races displayed on a large screen in front of the iCycle: the more voluntary effort the participant contributes the greater the speed of the avatar. During cycling, a motor will control cycling speed, and muscle stimulation (FES) will be applied to the leg muscles (right and left gluteus, quadriceps and hamstrings) on alternative revolutions of the pedals. A dashboard screen will display controls for the stimulation, speed, brake, game switch and an emergency stop. Sessions will increase from 20 mins or the maximum achievable at the start (whichever is lower) up to at least 1 hour.

Outcomes

Primary Outcome Measures

Change in International Standards of Neurological Classification for SCI (ISNC-SCI) Motor score.
This is a is a clinician-administered scale used to classify the severity (completeness) of injury in individuals with SCI.

Secondary Outcome Measures

Change in Trunk Impairment Scale (TIS) score
The TIS scores, on a range from 0 to 23, static and dynamic sitting balance as well as trunk co-ordination. It aims to score the quality of trunk movement and to be a guide for treatment.
Change in Walking Index for Spinal Cord Injury (WISCI II) score
Assessment index to assess ability of walking after SCI. This is quantified using rank ordering and dimension of impairment from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance
change in 6-minute walk test (6MWT) distance
A submaximal exercise test that measures the distance walked over a span of 6 minutes
Threshold of evoked responses to Transcranial Magnetic Stimulation (TMS)
TMS is used to activate the motor cortex, and motor evoked potentials (MEPs) are measured in lower limb muscles using electromyography, Threshold to elicit MEPs is measured in each muscle.
Audio/transcribed feedback from participants from semi-structured interview
A semi-structured interview will be conducted to assess the participants experience in the trial, the training intervention and using the iCycle.

Full Information

First Posted
May 7, 2021
Last Updated
August 15, 2023
Sponsor
University College, London
Collaborators
University of Southampton
search

1. Study Identification

Unique Protocol Identification Number
NCT04902482
Brief Title
iCycle II: Recovery of Function Through FES Cycling With VR Biofeedback in People With SCI.
Acronym
iCycle
Official Title
Recovery of Function Through Cycling Therapy With Virtual Reality Biofeedback in Chronically Spinal Cord-injured People
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 6, 2022 (Actual)
Primary Completion Date
January 31, 2024 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College, London
Collaborators
University of Southampton

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The annual incidence of traumatic spinal cord injury (SCI) is estimated at 2,500 (35 per week) in the UK and, due to advances in research and clinical management, the majority now have incomplete injuries, with significant potential for neurological improvement. Discovering ways to provide intensive, but cost-effective SCI rehabilitation is therefore increasingly important. The iCycle combines functional electrical stimulation (FES) cycling with VR cycle-racing feedback, where winning correlates with voluntary effort, to promote recovery. The aim is to improve walking in people with incomplete injuries, fundamental to independence and quality of life as well as long-term health. More intensive rehabilitative training is associated with better outcomes: the iCycle has the potential to increase intensity of exercise without additional demands on therapists' time and therefore cost. Following the encouraging results in an initial study; it is now important to find out whether recovery will continue at a similar rate if iCycle training continues beyond 4 weeks. Six volunteers with SCI will be recruited to participate in this 20 week, single-site open feasibility trial. The trial consists of an intervention phase lasting up to 12 weeks (3 iCycle sessions per week), and an 8-week follow-up phase. Outcome measures (ISNC-SCI motor scoring, Trunk Impairment scale, Walking Index for Spinal Cord Injury, 6-minute walk test, Goal Attainment Scale and TMS) will be taken every 4 weeks. The 12-week intervention phase will be separated into three 4-week blocks; at the end of each block participants may decide whether or not they wish to continue training.
Detailed Description
Recruitment: Participants will be recruited from London Spinal Cord injuries Centre (LSCIC) at the Royal National Orthopaedic Hospital (RNOH) where the training intervention will be carried out. The study will also be advertised via relevant newsletters, bulletin boards, websites and mailing lists. For each recruited participant, the study will be conducted for up to 20 weeks in total*. This includes: an intervention phase lasting up to 12 weeks and an 8-week follow-up phase. Outcome measure (OM) assessments will be carried out every 4 weeks (OM1-6) to collect study variables. OM assessments will be conducted by either the researcher or physiotherapist. Each OM assessment session will be broken into two parts, each lasting 2 hours. * At the end of each 4-week block in the intervention phase, participants will be given the option to continue training for the next 4-week block, or to stop training. Intervention Phase: Visit 1: During first outcome measure visit (OM1), participants will attend the Aspire Create labs at the RNOH in Stanmore, where they will be given the opportunity to ask questions about the study, informed consent to participate in the study will be taken and demographic information recorded in the Case Report Form (CRF). Visits 2-38; 36 training sessions (3days/week) & 3 sessions Outcome measure assessments (OM 2-4) During the intervention phase, participants will attend 3 training sessions per week for up to 12 weeks (participants may opt to withdraw from training after 4 or 8 weeks and, if they choose to withdraw, will be advanced to the follow-up phase); each session will last from 20 mins-1 hour depending on the maximum achievable endurance (plus an additional <30 mins for set-up in iCycle). Stimulation parameters will be recorded for each participant before training starts and a training diary will be completed during each training session. During each training session Electrodes will be placed on the quadriceps, hamstring and gluteal muscles. Participants will be able to tether their wheelchair (from under the seat) to the front of the iCycle for security and hold the handlebars provided on the dashboard while cycling for further stability. These can be adjusted for comfort. Muscle stimulation (FES) will be applied to the leg muscles on alternative revolutions of the pedals during a virtual reality cycle race(s). The more voluntary effort the greater the speed of the avatar. Training will increase from 20 mins or the maximum achievable at the start (whichever is lower) up to at least 1 hour. Outcome measures (OM 2-4) will be performed every 4 weeks during the intervention phase (on a separate day to training sessions). The same outcome measures conducted in the baseline phase are repeated here with the addition of an audio recorded interview conducted in the OM4 appointment. Follow-up Phase: Visits 39-40 - 2 sessions Outcome measures (OM 5-6) Following termination of training, no further intervention will be given. Outcome measure assessments (OM 5-6) will be performed every 4 weeks during the 8-week follow-up phase.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
Keywords
Rehabilitation, FES cycling, Virtual Reality, Biofeedback, Motor Function

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
iCycle training
Arm Type
Experimental
Arm Description
Participants will attend 3 training sessions per week at the RNOH. During these sessions, participants will tether their wheelchair (from under the seat) to the front of the iCycle, and their feet will be attached to the iCycle pedals. For training, participants will complete virtual reality cycle races displayed on a large screen in front of the iCycle: the more voluntary effort the participant contributes the greater the speed of the avatar. During cycling, a motor will control cycling speed, and muscle stimulation (FES) will be applied to the leg muscles (right and left gluteus, quadriceps and hamstrings) on alternative revolutions of the pedals. A dashboard screen will display controls for the stimulation, speed, brake, game switch and an emergency stop. Sessions will increase from 20 mins or the maximum achievable at the start (whichever is lower) up to at least 1 hour.
Intervention Type
Device
Intervention Name(s)
iCycle Mark 3
Intervention Description
The iCycle Mark 3 is a cycle ergometer, designed to be used by people with SCI while they are seated in their own wheelchairs. The purpose of iCycle is to stimulate the leg muscles in the correct phase for cycling while motivating the person with a Virtual Reality cycling event, perhaps a race, to try to use their muscles.
Primary Outcome Measure Information:
Title
Change in International Standards of Neurological Classification for SCI (ISNC-SCI) Motor score.
Description
This is a is a clinician-administered scale used to classify the severity (completeness) of injury in individuals with SCI.
Time Frame
15 minutes
Secondary Outcome Measure Information:
Title
Change in Trunk Impairment Scale (TIS) score
Description
The TIS scores, on a range from 0 to 23, static and dynamic sitting balance as well as trunk co-ordination. It aims to score the quality of trunk movement and to be a guide for treatment.
Time Frame
15 minutes
Title
Change in Walking Index for Spinal Cord Injury (WISCI II) score
Description
Assessment index to assess ability of walking after SCI. This is quantified using rank ordering and dimension of impairment from most severe impairment (0) to least severe impairment (20) based on the use of devices, braces and physical assistance
Time Frame
15 minutes
Title
change in 6-minute walk test (6MWT) distance
Description
A submaximal exercise test that measures the distance walked over a span of 6 minutes
Time Frame
15 minutes
Title
Threshold of evoked responses to Transcranial Magnetic Stimulation (TMS)
Description
TMS is used to activate the motor cortex, and motor evoked potentials (MEPs) are measured in lower limb muscles using electromyography, Threshold to elicit MEPs is measured in each muscle.
Time Frame
60 minutes
Title
Audio/transcribed feedback from participants from semi-structured interview
Description
A semi-structured interview will be conducted to assess the participants experience in the trial, the training intervention and using the iCycle.
Time Frame
30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: >18 years Incomplete SCI above T12 >12 months post injury Respond to FES No deteriorating condition or other co-morbidity that would make participation impractical or unsafe. Marginal walker defined as able to rise from a chair, stand for 10 seconds and walk >10 steps without human help (but may use an aid including parallel bars). Exclusion Criteria: Cardiac pacemaker Pressure sores/skin problems Unhealed lower limb fractures Pregnancy Active heterotrophic ossification - lower limbs Severe osteoporosis Complex regional pain syndrome Implanted metal work at electrode site (< 3/12) Lower Limb Malignancy T6 and below spinal malignancy Uncontrolled autonomic dysreflexia History of knee dislocation/subluxation Allergy to electrodes Cognitive difficulties - must be able to demonstrate an understanding of the iCycle and the virtual reality cycling game Severe spasticity - Ashworth scale 4 or 5 in any lower limb muscle groups Neurological degenerative diseases
Facility Information:
Facility Name
Royal National Orthopaedic Hospital
City
Stanmore
State/Province
Middlesex
ZIP/Postal Code
HA74LP
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lynsey Duffell, PhD
Phone
+44 20 3108 9847
Email
l.duffell@ucl.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
As the study is only 6 participants IPD will be provided in study publications.
Links:
URL
https://www.ucl.ac.uk/surgery/research/research-department-orthopaedics-and-musculoskeletal-science/aspire-create
Description
Aspire CREATe website

Learn more about this trial

iCycle II: Recovery of Function Through FES Cycling With VR Biofeedback in People With SCI.

We'll reach out to this number within 24 hrs